medline.ch Onkologie Urologische Tumoren

	Can PARP Inhibitors Benefit Patients with Homologous Recombination Repair-Proficient Castration-Resistant Prostate Cancer? A Meta-analysis. Target Oncol Zhou S, Desai D, Kishi N, Benjamin S, Tsao CK. PMID: 41335286 [PubMed - as supplied by publisher]
	Mendelian randomization analysis integrating GWAS and eQTL data identified potential regulatory genes associated with prostate cancer in neural cells. Discov Oncol Guo J, Xie H, Yin Q, Dong C, Yang Y, Cha J, Yang J, Li X, Li Y, Xu F, Lin C. PMID: 41335165 [PubMed - as supplied by publisher]
	Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study. Front Public Health Sv, Standara M, Malatincová T, Staník M, Miklánek D, Hejcmanová K, Pacal M, Hrabec R, Ngo O, Hejduk K, K, Uher M, Májek O, Poprach A. PMID: 41334411 [PubMed - indexed for MEDLINE]
	Effect of Urethrovesical Anastomotic Leakage on Incontinence Following Robotic Radical Prostatectomy. JSLS Kilic M, Madendere S, Koseoglu E, Baygül A, Balbay MD. PMID: 41333989 [PubMed - indexed for MEDLINE]
	N-Acetylcysteine Role in Maintaining Renal Function in Cancer Patients with Cisplatin-Based Chemotherapy. Int J Nephrol Renovasc Dis Prabu OG, Islami NN, Mellenia J, Nugroho P, Rajabto W, Shatri H. PMID: 41333762 [PubMed]
	PANoptosis-related gene clusters and prognostic risk model in clear cell renal cell carcinoma. Front Genet Zhao Q, Xie H, Li C, Xiong Y, Fan Y, Huang Y, Zhan Y, Zeng S. PMID: 41332473 [PubMed]
	Global, regional, and national burden of bladder cancer from 1990 to 2021 with projections to 2050: insights from the global burden of disease study and Mendelian randomization analysis. Infect Agent Cancer Wang Y, Liu Z, Liu C. PMID: 41331629 [PubMed - as supplied by publisher]
	A Clinically Practical Nomogram for Predicting Survival in Elderly Patients (â‰¥â€‰65â€‰Years) With Bladder Urothelial Carcinoma: A Study Based on SEER Database and External Validation. Cancer Rep (Hoboken) Wei J, Wei C, Chen J, Zhang X, Zhao W. PMID: 41331282 [PubMed - indexed for MEDLINE]
	Disitamab vedotin (RC48-ADC) combined with immunotherapy as neoadjuvant therapy for localized muscle-invasive bladder cancer: a multicenter real-world study. NPJ Precis Oncol Guo X, Wang S, Ma Y, Du Y, Chen Y, Wang Q, Yang K, Tang Q, Fan Y, Hao H, He Z, Gong Y, Zhang C. PMID: 41331072 [PubMed - as supplied by publisher]
	Cadaveric evidence on lymph node counts and grossing accuracy in pelvic lymph node dissection for prostate cancer staging. Sci Rep Tunksakul P, Piyaman P, Woranisarakul V, Wanvimolkul N, Sovikul K, Mahamongkol K, Ratanayotha A. PMID: 41331023 [PubMed - as supplied by publisher]
	Is There a Role of FAPI Pet in Renal and Bladder Cancer? Semin Nucl Med Filippi L, Mass ACL, Arslan E, Alç, Guglielmo P, Evangelista L. PMID: 41330807 [PubMed - as supplied by publisher]
	New targets of PET imaging for renal cancer. Semin Nucl Med Katayeu Y, Grünwald V, Pabst KM, Yesilyurt UU, Al-Nader M, Fendler WP, Hadaschik BA, Herrmann K, Küper AT. PMID: 41330806 [PubMed - as supplied by publisher]
	Homologous Recombination Repair genetic testing variables and diagnostic paths for Prostate Cancer patients: a multicenter cohort study. Oncologist Incorvaia L, Puglisi M, Maruzzo M, Mammone G, Caffo O, Procopio G, Antonuzzo L, Rizzo M, Conteduca V, Messina C, Scagliarini S, Maiorano B, Santoni M, Facchini G, Lipari H, Formisano L, Stellato M, Basso U, Rossetti S, Lai E, Arcara CC, Bronte E, Bazan Russo TD, Colletta G, Gristina V, Pepe F, Malapelle U, Santini D, Depetris I, Di Maio M, Badalamenti G, Bracarda S, Russo A. PMID: 41330714 [PubMed - as supplied by publisher]
	Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer. Cancer Treat Rev Lin C, Hadfield MJ, Rathore A, Pinho-Schwermann M, Zhang S, Lu S, Hollander PD, Mani SA, Seyhan AA, Santopietro A, Mega A, Cheng L, El-Deiry WS, Carneiro BA. PMID: 41330005 [PubMed - as supplied by publisher]
	Newly Designed Optical Coherence Tomography Catheter for Optimizing Bladder Cancer Diagnosis and Treatment: Protocol for a Feasibility Study. JMIR Res Protoc Remmelink MJ, Nieuwenhuijzen JA, de Bruin DM, Oddens JR. PMID: 41329952 [PubMed - indexed for MEDLINE]
	Comparison of first-line immuno-oncology combinations with molecular targeted therapy in patients with advanced renal cell carcinoma undergoing hemodialysis: a real-world multicenter retrospective study. Int J Clin Oncol Ueda K, Kurata H, Murakami Y, Minato A, Shiota M, Nakanishi S, Kiyoshima K, Inoue T, Kumagae H, Irie S, Noguchi M, Tatarano S, Matsuzaki H, Tokuda Y, Sawada A, Abe T, Oshiro Y, Harada S, Igawa T. PMID: 41329256 [PubMed - as supplied by publisher]
	A Comparative Study of the Global Burden of Prostate Cancer (1990-2021): Emphasis on the Disparities Between the United States and China. Prostate Li J, Wu Y, Hou J, Liu H, Wang Y, Zhang F, Gu P, Liu X. PMID: 41329033 [PubMed - as supplied by publisher]
	18F-PSMA PET/CT and mpMRI: A combined approach for enhanced risk stratification in prostate cancer-a diagnostic accuracy study. Medicine (Baltimore) Aihemaitijiang M, Zhu H, Che K, Li K, Wumaner A, Li S, Gong H, Shi Z. PMID: 41327708 [PubMed - indexed for MEDLINE]
	Exosomal miRNAs versus circulating tumor DNA: diagnostic accuracy for early detection of recurrence post-radical prostatectomy: A narrative review. Medicine (Baltimore) Bashir H, Afzal MW, Mehmood A, Afzal M, Hassan MW, Parveen A. PMID: 41327686 [PubMed - indexed for MEDLINE]
	Male infertility and the risk of developing prostate cancer: a bidirectional two-sample Mendelian randomization study. Eur J Med Res Shao J, Apizi A, Zheng X, Tao N, An H. PMID: 41327353 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 174192

Seite 1 von 8710

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung